benzyl nicotinate, 94-44-0

Articles:

Google Patents:	Use of Benzyl Nicotinate for Pain Relief
PubMed:	Effects of water activity and low molecular weight humectants on skin permeability and hydration dynamics - a double-blind, randomized and controlled study.
PubMed:	Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.
PubMed:	Two 1,4-dihydropyridine derivatives with potential calcium-channel antagonist activity.
PubMed:	Degradation kinetics of benzyl nicotinate in aqueous solution.
PubMed:	Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.
PubMed:	Measurement of drug and macromolecule diffusion across atherosclerotic rabbit aorta ex vivo by attenuated total reflection-Fourier transform infrared imaging.
PubMed:	In situ permeation study of drug through the stratum corneum using attenuated total reflectance [corrected] Fourier transform infrared spectroscopic imaging.
PubMed:	Enhancement of bioavailability by lowering of fat content in topical formulations.
PubMed:	Estimation of serum protein binding of compounds metabolized in serum using matrix inhibition.
PubMed:	Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation.
PubMed:	N-Benzyltetrahydropyrido-anellated thiophene derivatives: new anticholinesterases.
PubMed:	Kinetics of blood flow after topical application of benzyl nicotinate on different anatomic sites.
PubMed:	Comparison of blood flow to the cutaneous temperature and redness after topical application of benzyl nicotinate.
PubMed:	In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry.
PubMed:	In vivo study of different ointments for drug delivery into oral mucosa by EPR oximetry.
PubMed:	Skin oxygenation after topical application of liposome-entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size.
PubMed:	Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivo.
PubMed:	Different effects of 4-(4'-chlorobenzyloxy)benzoic acid (MII) on lipid synthesis and cell growth in human and mouse skin fibroblasts.
PubMed:	Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
PubMed:	Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats.
PubMed:	[Experimental nephrotic hyperlipidemia induced in rats by daunorubicin and effects of KCD-232[4-(4'-chlorobenzyloxy)benzyl nicotinate] on lipid metabolism].
PubMed:	Percutaneous absorption in man: a kinetic approach.
PubMed:	Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats.
PubMed:	[Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
PubMed:	[Treatment of painful muscular disorders of various degrees of severity. Comparison of 2 new suppository preparations].
PubMed:	[Short-term therapy of painful muscular disorders. Results of a multicenter double-blind test of 2 new suppository preparations with and without codeine].
PubMed:	[Increased effectiveness of high-dose salicylate cream by iontophoresis].
PubMed:	Effect of benzyl nicotinate on the percutaneous absorption of dexamethasone in the rat.